Tag: GeneDX

VCV000038126.28 Observations – ClinVar – NCBI

1 SCV000301220.2 Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Pathogenic reviewed by expert panel curation Breast-ovarian cancer, familial, susceptibility to, 2 (unknown ) germline Variant allele predicted to encode a truncated non-functional protein. 1 SCV000785901.2 Counsyl Pathogenic criteria provided,single submitter clinical testing Breast-ovarian cancer, familial, susceptibility to,…

Continue Reading VCV000038126.28 Observations – ClinVar – NCBI

VCV000698353.6 – ClinVar – NCBI

Likely benign (Nov 17, 2018) criteria provided, single submitter Method: clinical testing Arrhythmia Affected status: unknown Allele origin: germline Color Health, Inc Accession: SCV001358509.1 Submitted: (May 19, 2020) Likely benign (Apr 19, 2020) criteria provided, single submitter Method: clinical testing Long QT syndrome Affected status: unknown Allele origin: germline Invitae…

Continue Reading VCV000698353.6 – ClinVar – NCBI

VCV000445854.7 Observations – ClinVar – NCBI

1 SCV000610624.1 Center for Pediatric Genomic Medicine,Children’s Mercy Hospital and Clinics Benign criteria provided,single submitter clinical testing not provided (not provided ) germline 1 SCV000700353.2 Eurofins NTD, LLC Uncertain significance criteria provided,single submitter clinical testing 1 not provided (unknown ) germline 1 Single Heterozygote www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CYP21A2 mixed 1 SCV001137083.1 Mendelics Benign…

Continue Reading VCV000445854.7 Observations – ClinVar – NCBI

GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset the largest of its kind…

Continue Reading GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GeneDx Announces the Sequencin – GuruFocus.com

GAITHERSBURG, Md., Sept. 21, 2021 GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset…

Continue Reading GeneDx Announces the Sequencin – GuruFocus.com

Expanding the diagnosis for Xia-Gibbs Syndrome

Xia-Gibbs Syndrome (XGS) is a rare genetic disorder that results in severe developmental delay, sleep apnea, delayed speech and upper body weakness. Image courtesy of the National Human Genome Research Institute In 2014, a team led by Dr. Richard Gibbs, director of the Human Genome Sequencing Center and Wofford Cain Chair and…

Continue Reading Expanding the diagnosis for Xia-Gibbs Syndrome

GeneDx hiring DNA Sequencing Lab Technician I (FT, 40 Hours, On-site) in Gaithersburg, Maryland, United States

GeneDx is a rapidly growing CAP and CLIA certified diagnostic genetic testing laboratory for molecular genetics. Our historic mission has been to make clinical diagnostic testing available for people with genetic conditions and their families. We apply cutting edge technologies that provide a wide array of molecular genetic diagnostic tests,…

Continue Reading GeneDx hiring DNA Sequencing Lab Technician I (FT, 40 Hours, On-site) in Gaithersburg, Maryland, United States